Success Story: A Medical Sciences Expert Secures I-140 NIW Approval for Work Advancing Safer AI in Healthcare

Client’s Testimonial:

 

"Thank you again for all your help with my EB2-NIW approval!”

 


 

On April 27th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the Field of Medical Sciences (Approval Notice).

 


 

General Field: Medical Sciences

 

Position at the Time of Case Filing: Research Fellow

 

Country of Origin: Pakistan

 

State of Residence at the Time of Filing: Florida

 

Approval Notice Date: April 27th, 2026

 

Processing Time: 3 months, 18 days (Premium Processing Upgrade Requested)

 


 

Case Summary:

 

We are pleased to share another I-140 NIW approval for a medical sciences expert whose work focuses on developing advanced healthcare technology through artificial intelligence, machine learning, retrieval-augmented generation models, and wearable sensor integration. The client’s proposed endeavor was framed around improving patient experience, strengthening surgical decision-making, reducing disparities in medical outcomes, and establishing ethical frameworks for safer clinical AI implementation.

 

Building the Foundation

 

The client is currently employed as a research fellow in a patient-contact role, where the client continues to pursue research at the intersection of medicine, AI-based clinical decision support, and patient-centered healthcare technology. This position helped support the petition’s broader argument that the client has a credible and ongoing path to continue advancing the proposed endeavor in the United States.

 

Documenting Excellence

 

The client’s record of achievement provided strong support for this positioning. We documented 51 peer-reviewed journal articles, including 10 first-authored articles, as well as 29 abstracts, including 2 first-authored abstracts. These numbers were not treated as self-evidently sufficient. Instead, the petition explained how the breadth of this publication record showed sustained research productivity across medical sciences, clinical AI, surgical decision support, and technology-driven healthcare improvement.

 

The petition also documented 681 citations to the client’s published work. From an adjudicative perspective, this citation evidence helped show that other researchers were not merely aware of the client’s work but were actively relying on the client’s findings to support later studies involving AI applications in healthcare, large language models, clinical decision support, and ethical AI deployment.

 

In addition, the client had completed at least 5 peer reviews and held an editorial role connected to AI and digital technology in clinical medicine. We used this evidence to show peer trust. In an NIW context, peer review and editorial responsibilities can help demonstrate that the field views the client as someone capable of evaluating the quality, rigor, and relevance of other researchers’ work.

 

The petition also noted that the client’s research had received support from major philanthropic funding sources. We presented this funding evidence as an objective indicator that the client’s work aligns with broader priorities in healthcare innovation, technology access, and public benefit, rather than as a standalone credential.

 

NIW Approval and Outlook

 

We are honored to have supported the client in this successful I-140 NIW petition without RFE and wish the client continued success in advancing AI-driven healthcare technologies that can improve patient care, clinical safety, and equitable medical outcomes in the United States.